Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5680_Библиотеки_им_академика_М_И_Перельмана
.pdf
hydrotropic extraction method,
162–164
3-hydroxy-3-methylglutaryl-CoA
reductase (HMG-CoA-R), 59
5-hydroxy-7-(4
0
-hydroxy-3
0
-methoxy-
phenyl)-1-phenyl-3-heptanone
(HPH), 272
4
0
-hydroxycinnamaldehyde (4
0
-HCA),
262
6-hydroxydopamine (6-OHDA),
85, 95
5-hydroxytryptamine (5-HT), 98
hypertension, effect on, 65
hypolipidaemic activity
in vitro studies, 272 –273
in vivo studies, 273
IBS. See irritable bowel syndrome
(IBS)
ICMR. See Indian Council for
Medical Research (ICMR)
IFN. See interferon (IFN)
IGF. See insulin-like gro wth factor
(IGF)
IgG. See immunoglobulin G (IgG)
IgM. See immunoglobulin M (IgM)
IL. See interleukin (IL)
IL-1b. See interleukin 1 beta
(IL-1b)
IL-2. See interleukin-2 (IL-2)
IL-6. See interleukin 6 (IL-6)
ILI. See influenza like illness (ILI)
ILs. See ionic liquids (ILs)
imidazolium ions, 123
immune response system, 82
immune system, 237
immunoglobulin G (IgG), 100
immunoglobulin M (IgM), 100
IND. See investigational new drug
(IND)
Indian Council for Medical Research
(ICMR), 333
Indian ginseng, 89–90
Indian gooseberry (Emblica officinalis),
152–154, 221, 382
Indian long pepper, 152
Indian traditional medicine systems,
403
Ayurveda, 404
Siddha, 404
Unani, 404–405
inducible nitric oxide synthase
(iNOS), 307
influenza like illness (ILI), 410
infra-red (IR), 297
iNOS. See inducible nitric oxide
synthase (iNOS)
INR. See international normalized
ratio (INR)
insulin-like growth factor (IGF),
299
intellectual property (IP), 363
interferon (IFN), 100
interferon gamma (IFN-g), 60
interleukin (IL), 299, 306
extraction method, 124
interleukin 1 beta (IL-1b), 59
interleukin 6 (IL-6), 59
interleukin-2 (IL-2), 100
international normalized ratio (INR),
410
investigational new drug (IND),
367
ionic liquids (ILs), 123, 166
ultrasonic extraction process
that uses ionic liquids
(ILUAE), 166
ionic-liquid extraction method,
123–124, 166–167
IP. See intellectual property (IP)
IR
. See infra-red (IR)
iron, 7–8
irritable bowel syndrome (IBS),
227
Japan, Kampo, traditional medicine
of, 405–406
Ju Ye Zong in Traditional Chinese
Medicine, 412
Kaempferia galangal,79
kajjali, 3, 5–6, 15
432 Subject Index
https://t.me/med1917
Kampo
clinical evidence for, 411–412
traditional medicine of Japan,
405–406
kapha, 26, 46, 49, 74, 328
11-keto-b-boswellic acid, 76
Khalvi Rasa,5
kidney health, protective
effect on, 61
Koflet syrup, 116
Kupipakwa Rasa, 5–6
Kurex light syrup, 116–117
Kushta (Saussurea lappa), 180
kushtaroga, 31–32
L-arabinose, 17
L-NAME
. See L-nitro-arginine methyl
ester (L-NAME)
L-nitro-arginine methyl ester
(L-NAME), 58
Lauha Kapibadkva,2
Laura Kalpa,3
LDL-cholesterol. See lipoprotein-
cholesterol (LDL-cholesterol)
lead, 8
compound optimization,
327–328
compound screening, 327
lesser galangal, 251
leukotriene B4 (LTB4), 85
lipid
compounds, 297
profile modulation, 243–244
5-lipooxygenase (5-LOX), 273, 307
lipopolysaccharide (LPS), 307
lipoprotein-cholesterol (LDL-
cholesterol), 308
liquid–liquid extractions (LLE), 124
Listeria monocytogenes, 263
liver, 84
protective effect on liver health,
60–61
liver X receptor (LXRa), 59
LLE. See liquid–liquid extractions
(LLE)
loha,8
Loha Bhasma, 3, 114
Lohaadi Rasayana,9
Lohitikarna,3
long pepper (Piper longum), 49, 150
LPS. See lipopolysaccharide (LPS)
LTB4. See leukotriene B4 (LTB4)
LXRa. See liver X receptor (LXRa)
M-Cof syrup, 116
Maarana, 3–4
Madhava Upadhyaya,8
Madhu (Honey), 229
MAE. See microwave-assisted
extraction (MAE)
male sterility, 55–56
malondialdehyde (MDA), 62, 172
Manahas
´
ila, 3
Manasamitra vataka, 114
Mandura,8
Mandura Bhasma,8
MAO-A. See monoamine oxidase-A
(MAO-A)
MAP-2. See microtubule-associated
protein-2 (MAP-2)
Maricha, 116, 150, 154
matrix metalloproteinase (MMP-9),
262
maximal electroshock (MES), 181
MBC. See minimum bactericidal
concentration (MBC)
MCI. See mild cognitive impairment
(MCI)
MCP-1. See membrane cofactor
protein (MCP-1)
MDA. See malondialdehyde (MDA)
MDOADs. See muscular dystrophy
during osteoarthritic disorders
(MDOADs)
Medhya rasayana, 177, 181
medicinal plants, 297
medicine, 73. See also traditional
medicines
African traditional healthcare
system, 413
Australian aboriginal tradi-
tional medic ine, 413
Subject Index 433
https://t.me/med1917
(continued)
clinical study in traditional
medicine, 406–413
tailoring of study designs,
413–414
traditional systems of, 374
membrane cofactor protein
(MCP-1), 85
mercury, 5–7
MES.Seemaximal electroshock (MES)
messenger ribonucleic acid
(mRNA), 60
metabolic syndrome and Triphala,
215–216
metals used to develop various
herbal formulas under Rasa
Rasayana, 5–9
metformin (Galega officinalis),
80, 363
1 methyl-4-phenylpyridinium
(MPP þ), 240
microsomal triacylglycerol transport
protein (MTP), 59
microtubule-associated protein-2
(MAP-2), 93
microwave-assisted extraction
(MAE), 121–122, 124, 166
mild cognitive impairment(MCI), 410
mineral drugs, 3
minimum bactericidal concen-
tration (MBC ), 264
MLD-STZ. See multiple low-dose
streptozotocin (MLD-STZ)
modaka,9
molecules, 232
monoamine oxidase-A (MA O-A), 240
morphine, 363, 392
MPO. See myeloperoxidase (MPO)
mRNA. See messenger ribonucleic
acid (mRNA)
MTP. See microsomal triacylglycerol
transport protein (MTP)
Mucuna pruriens, 333
multiple low-dose streptozotocin
(MLD-STZ), 80
muscle wasting diseases, 310
muscular dystrophy during osteo-
arthritic disorders (MDOADs), 305
Musta (Cyperus rotundus), 26, 229
myeloperoxidase (MPO), 306
myrobalans, 201
NADPH. See nicotinamide adenine
dinucleotide phosphate (NADPH)
NADPH oxidase 4 (NOX4), 301
Naja naja. See cobra (Naja naja)
Nakuli, 251
nanotechnology
AgNPs, 311
AuNPs, 311
CQ in, 310–311
CuONPs, 311
Nasta puspantaka rasa, 114
National Medicinal Plants Board
(NMPB), 177
natural products (NPs), 123
nausea, management of, 63
NDA.Seenew drug application (NDA)
NEC. See necrotizing enterocolitis
(NEC)
necrotizing enterocolitis (NEC), 61
nervous system and Triphala,
214–215
neurofilament-H (NF-H), 93
new drug application (NDA),
328, 367
new drugs
Ayurvedic medicinal pla nts,
334–362
development of, 334
from natur al resources, 334
NF-H
. See neurofilament-H (NF-H)
NF-kB. See nuclear factor kappa-
light-chain-enhancer of activated
B cells (NF-kB)
nicotinamide adenine dinucleotide
phosphate (NADPH), 59
NIDDM. See non-insulin dependent
diabetes mellitus (NIDDM)
Niemann–Pick C1-like protein 1
(NPC1L1), 59
Nimba (Azadirachta indica), 26, 333
434 Subject Index
https://t.me/med1917
Nishamalaki, 231
nitric oxide (NO), 96, 132, 273, 301
NMPB. See National Medicinal
Plants Board (NMPB)
NMR. See nuclear magnetic reson-
ance (NMR)
NO. See nitric oxide (NO)
non-insulin dependent diabetes
mellitus (NIDDM), 136
nonsteroidal anti-inflammatory
drugs (NSAID), 133, 237, 408
NOX4. See NADPH oxidase 4 (NOX4)
NPC1L1. See Niemann–Pick C1-like
protein 1 (NPC1L1)
NPs. See natural products (NPs)
Nrf2. See nuclear factor erythroid 2-
related factor 2 (Nrf2); nuclear
transcription factor-2 (Nrf2)
NSAID. See nonsteroidal anti-
inflammatory drugs (NSAID)
nuclear factor erythroid 2-related
factor 2 (Nrf2), 59
nuclear factor kappa-light-chain-
enhancer of activated B cells
(NF-kB), 31, 59, 85
nuclear magnetic resonance (NMR),
92, 297
nuclear transcription factor-2
(Nrf2), 307
nutraceuticals, evidence-based
formulations in, 57–59
3-o-acetyl-11-keto beta boswellic acid
(AKBA), 76
OA. See osteoarthritis (OA)
obesity, 36
obsessive-compulsive disorder
(OCD), 98
OCD. See obsessive-compulsive
disorder (OCD)
Ocimum americanum, 108
Ocimum basilicum. See Ban tulsi
(Ocimum basilicum)
Ocimum camphora, 108
Ocimum canum. See dulal tulsi
(Ocimum canum)
Ocimum gratissimum. See Ram tulsi
(Ocimum gratissimum)
Ocimum killimandscharicum, 108
Ocimum miranthum, 108
Ocimum sanctum, 108, 381
anthelmintic activity, 135–136
antiarthritic activity, 135
anticancer, 130–131
antidiabetic activity, 136–137
antihyperlipidemic activity,
134–135
antiinflammatory activity,
132–133
antimicrobial properties,
126–130
antiulcer activity, 133
Ayurvedic significance and
ethnopharmacological
relevance, 110–111
botanical description, 111–112
chemical constituents, 112–113
different ancient Ayurvedic
formulations containing
Tulsi, 114–115
different modern formulations
available containing Tulsi,
115–118
effect on central nervous sys-
tem, 133–134
geographical distribution, 111
hepatoprotective activity, 131
immunomodulatory activity,
131–132
modern techniques of ex-
traction, 118–126
pharmacological profile, 126
Operculina turpethum,10
OPG. See osteoprotegrin (OPG)
opium plants (Papaver
somniferum), 392
orientin, 112
Oshadhi Varga, 23
osmotic pressure, 164
osteoarthritis (OA), 31, 77, 305,
377, 407
osteoprotegrin (OPG), 299
Subject Index 435
https://t.me/med1917
ovarian cancer, 96–97
oxidative stress, 65
p-hydroxycinnamaldehyde, 266
paclitaxel (Taxusbrevifolia), 363, 392
PAM. See proprietary Ayurvedic
medicines (PA M)
Pancha karma, 329
therapy, 329
panchamahabhuta, 404
panduroga, 26, 28, 31
PANSS. See Positive and Negative
Syndrome Scale (PANSS)
paracetamol (PCM), 84
Pareeksha tools, 334
Parkinson’s disease (PD), 95,
333, 409
Parpati Rasa , 5–6
Patola (Trichosanthes dioica), 229
PCM. See paracetamol (PCM)
PCNA. See proliferating cell nuclear
antigen (PCNA)
PD. See Parkinson’s disease (PD)
peak expiratory flow rate (PEFR), 409
PECs. See peritoneal exudates cells
(PECs)
PEF extraction. See pulsed electric
field extraction (PEF extraction)
PEFR. See peak expiratory flow rate
(PEFR)
penicillin G (Penicillium
citrinum), 363
Penicillium citrinum. See penicillin G
(Penicillium citrinum)
pepper species in Ayurvedic
formulations
Ayurvedic importance and eth-
nopharmacological rele-
vance, 149–150
black pepper, 148–149
botanical description, 151–152
clinical studies on black pep-
per, 167– 169
different ancient Ayurvedic
formulations prepared from
black pepper, 152–156
different modern formulations
available containing black
pepper, 156–158
geographical distribution,
150–151
modern techniques used in
extraction of Piper nigrum,
162–167
phytochemicals, 159–162
peppercorns, 151
Peraratta, 251
peritoneal exudates cells (PECs),
267
peroxisome proliferator-activated
receptor-a (PPARa), 244
peroxisome proliferator-activated
receptor d (PPARd), 66
PFA. See polyunsaturated fatty acid
(PFA)
PFK. See
phosphofructokinase (PFK)
PG. See prostaglandin (PG)
pharmaceutical industry, 363–367
pharmacokinetics and pharmacody-
namics (PK/PD), 36
phenolics, 301
phosphofructokinase (PFK), 136
phospholipase A2 (PLA2), 99
phosphorus, 291–292
Phyllanthaceae, 222
Phyllanthus emblica, 9–10, 46, 203
phytochemicals, 159, 235
different habitats and diversity
in, 161–162
fruits, 159–161
roots, 161
whole plant, 159
Piper, 150
Piper longum. See long pepper (Piper
longum); Pippali (Pip er longum)
Piper longum embelia,10
Piper nigrum. See black pepper (Piper
nigrum)
Piper retrofractum. See Chavak (Piper
retrofractum)
Piperaceae, 148
piperine, 35, 170
436 Subject Index
https://t.me/med1917
Pippali (Piper long um),26, 154,180, 228
Pippalye
¨
dye
¨
sava, 152
Piroxicam, 60
pitta, 328
PK/PD. See pharmacokinetics and
pharmacodynamics (PK/PD)
PKB. See protein kinase B (PKB)
PLA2. See phospholipase A2 (PLA2)
plant, 159, 403
fibers, 136
plant-derived products, 403
PLE. See pressurized liquid ex-
traction (PLE)
PLLA. See poly-
L-lactic acid (PLLA)
Pluchea lanceolate, 377
Plumbago zeylanica. See Ceylon
(Plumbago zeylanica)
Pneumonorm syrup, 117
PNS. See polar–nonpolar sandwich
(PNS)
Poecilia reticulata, 311
poison goos eberry, 89
polar–nonpolar sandwich (PNS), 59
poly-
L-lactic acid (PLLA), 311
polydopamine, 312
polyherbal formulations, 376–379
polyphenols, 232
polyunsaturated fatty acid (PFA), 16
Positive and Negative Syndrome
Scale (PANSS), 104
postsynaptic density protein-95
(PSD-95), 93
Pottali Rasa, 5–7
PPARa. See peroxisome proliferator-
activated receptor-a (PPARa)
PPARd. See peroxisome proliferator-
activated receptor d (PPARd)
prakritis, 331
prameha, 28–31
prenol lipid, 34–35
pressurized liquid extraction (PLE),
125–126
proliferating cell nuclear antigen
(PCNA), 96
proprietary Ayurvedic medicines
(PAM), 407
prostaglandin (PG), 273
prostaglandin E
2
(PGE
2
), 306
prostate cancer (CaP), 130
protein kinase B (PKB), 207
protein tyrosine phosphatase 1B
(PTP1B), 60
PSD-95. See postsynaptic density
protein-95 (PSD-95)
PTP1B. See protein tyrosine phos-
phatase 1B (PTP1B)
pulsed electric field extraction (PEF
extraction), 126
Pushpa,9
puta device, 4
Putapaaka process, 4
QoL. See quality of life (QoL)
quality of life (QoL), 377
quantitative insulin sensitivity check
index (QUICKI), 64
quercetin, 301
QUICKI. See quantitative insulin
sensitivity check index (QUICKI)
quinine, 362, 392
RA. See rheumatoid arthritis (RA)
RAGE. See receptor for advanced
glycation end-products expression
(RAGE)
Rakta moksha, 329
Ram tulsi (Ocimum gratissimum), 108
randomized controlled trials (RCTs),
368, 375–376, 407
RANKL. See receptor activator of
nuclear factor K Ligand (RANKL)
Ras-yoga,3
Rasa,3,5
Rasa Rasayana,3,6,12
metals used to develop various
herbal formulas under, 5–9
method of preparation of
Bhasma, 3–5
Rasa Vagbhata,8
rasapanchaka,23
Rasausadhies,5
Rasayana, 2, 379
Subject Index 437
https://t.me/med1917
Rasna, 251–252
in Ayurveda, 251–252
Rauwolfia serpentine, 362, 392
RBC. See red blood cell (RBC)
RCTs. See randomized controlled
trials (RCTs)
reactive oxygen species (ROS), 83, 96,
236, 301
real-world data (RWD), 368
receptor activator of nuclear factor K
Ligand (RANKL), 299
receptor for advanced glycation end-
products expression (RAGE), 59
red blood cell (RBC), 411
reducing power (RP), 265
REE. See resting energy expenditure
(REE)
reserpine, 133, 392
Respicare tablet, 116
resting energy expenditure
(REE), 172
reverse pharmacology, 331–333
rheumatoid arthritis (RA), 31, 407
Rhipicephalus microplus, 311
rhizome, 23, 258, 275
Rig Veda, 176
roots, 161, 291
ROS. See reactive oxygen species
(ROS)
Rosemarinus officinale, 305
RP. See reducing power (RP)
RWD. See real-world data (RWD)
1
0
S-1
0
-acetoxychavicol acetate
(ACA), 268
Sada pathyam, 222
Salmonella typhosa, 132
Sama Veda , 176
Sandhigata vata/Arthritis, 76–80
Sanskrit synonyms, 223
SAR. See Sarangadhara Samhita
(SAR)
Sarangadhara Samhita (SAR), 26
Sarasvata ghrita, 53, 180
Saraswatarishta, 181
Saraswati ghrita,10
sarcopenia, role in, 310
Sattvic Kapha Rasayana, 90
saturated fatty acids (SFAs), 16
Saussurea lappa. See Kushta (Saus-
surea lappa)
scaling and root planing (SRP), 169
scanning electron microscopy, 15
serum adiponectin, 242
serum gl ycaemic modulation,
242–243
SFAs. See saturated fatty acids (SFAs)
SFE. See supercritical fluid ex-
traction (SFE)
Shallaki
Ayurvedic properties of, 75
varg of Shallaki in different
literature sources, 75
Shatavari, 379
sheep erythrocytes, 132
shodhana, 3–4
Shorea robusta,9
shuddha dravya,4
Shunti, 154, 229
Siddha, 46–47
silver, 7
silver nanoparticles (AgNPs), 311
skin diseases, 31–32
skin disorders, 83
SLE. See solid–liquid extraction (SLE)
sloka,15
SOD.Seesuperoxide dismutase (SOD)
soft powder, 9
solid-phase extractions (SPE), 124
solid–liquid extraction (SLE), 124
solvent, pulverized carbon dioxide
(SCCO
2
), 165
SPE. See solid-phase extractions
(SPE)
SREBP2. See sterol regulatory
element-binding protein 2
(SREBP2)
Sri Sri Tulasi Arka, 117
SRP. See scaling and root planing
(SRP)
SS. See Susruta Samhita (SS)
Staphylococcus aureus, 263
438 Subject Index
https://t.me/med1917
StAR. See steroidogenic acute regu-
latory protein (StAR)
stem paste, 291
steroid sex hormones, 96
steroidogenic acute regulatory pro-
tein (StAR), 304
sterol regulatory element-binding
protein 2 (SREBP2), 59
streptozotocin (STZ), 136
STZ. See streptozotocin (STZ)
supercritical carbon dioxide ex-
traction (SC-CO
2
), 122–123
supercritical fluid extraction (SFE),
159, 164–165
superoxide dismutase (SOD), 301
Sushruta Samhita,7,9
Susruta Samhita (SS), 26
Swarna Bhasma,7
Syzygium aromaticum. See Eugenia
aromatica (Syzygium aromaticum)
T-helper 1 (Th1), 100
Taila,2,11
Talika,9
tannins, 232
tartrate resistant acid phosphatase
(TRAP), 304
Taxusbrevifolia. See paclitaxel
(Taxusbrevifolia)
TCM. See Traditional Chinese Medi-
cine (TCM)
TCP. See tricalcium phosphate (TCP)
Technology Information Forecasting
and Assessment Council (TIFAC),
178
TEM. See transmission electron mi-
croscopy (TEM)
Terminalia,9
T. bellirica, 9, 203–204, 376
T. chebula , 10, 227, 376
Terminalia belerica. See Bhenda
(Terminalia belerica)
Terminalia bellerica. See Bibhitaki
(Terminalia bellerica)
Terminalia bellirica. See Vibhitaki
(Terminalia bellirica)
Terminalia chebula. See Haritaki
(Terminalia chebula)
testosterone, 104
tetraalkylammonium cations, 123
tetrahydro cannabidiol (THC), 368
TG. See triglycerides (TG)
Th1. See T-helper 1 (Th1)
Thamzhil Maruthuvam, 46
THC.Seetetrahydro cannabidiol (THC)
thin-layer chromatography (TLC), 92
Thymus vulgaris, 271
thyroid problems, 56
TIFAC. See Technology Information
Forecasting and Assessment
Council (TIFAC)
tin, 8
Tinospora cordifolia. See Guduchi
(Tinospora cordifolia)
TLC. See thin-layer ch romatography
(TLC)
TNF.Seetumour necrosis factor (TNF)
TNF-a. See tumor necrosis factor
alpha (TNF-a)
traditional aboriginal medicine from
Australia, 406
Traditional Chinese Medicine
(TCM), 125, 391–392, 405
clinical ev idence for, 412–413
traditional medicines, 392
African traditional
healthcare, 405
clinical ev idence for Ayurveda,
406–411
clinical ev idence for Kampo,
411–412
clinical ev idence for TCM,
412–413
clinical stu dy in, 406
Indian traditional medicine
systems, 403–405
Kampo, traditional medicine of
Japan, 405–406
systems, 45, 403
TCM, 405
traditional aboriginal medicine
from Australia, 406
Subject Index 439
https://t.me/med1917
traditional plant-based systems of
medicine, 376
transmission electron microscopy
(TEM), 292
TRAP. See tartrate resistant acid
phosphatase (TRAP)
Tribhuvana kirti ras, 115
Tribulus terrestris,78
tricalcium phosphate (TCP), 312
Trichosanthes dioica. See Patola
(Trichosanthes dioica)
tridoshahara medicine, 227
triglycerides (TG), 272, 308
trimethoprim (Tm), 130
Triphala, 9, 229, 238, 376
anticancer activity and,
205–207
in Ayurveda and phytochemical
studies, 201
Ayurvedic perspective on,
202–203
bioactive components of,
203–205
cardiovascular health and, 214
immunomodulatory effect and,
207–214
metabolic syndrome and,
215–216
nervous system and, 214–215
Triphala effects on various
diseases, 205
way ahead for 216
Triphala Ghrita, 202
Triphala Guggul, 202
Triphala mashi, 202
Tulsi, 110, 114, 130, 132, 381
different modern formulations
available containing,
115–118
in India, 118
tumor necrosis factor alpha (TNF-a),
59, 85, 305
tumour necrosis factor (TNF), 31
turmeric (Curcuma longa L.), 10,
22–23, 180, 229, 305, 333, 377, 380
anaemia and panduroga, 31
antiarthritic and Vatarakta, 31
antidiabetic and Prameha,
28–31
data-mining classical texts for
insights, 24–28
phytochemical composition
and pharmacological
activities of, 32–38
powder, 31
rhizomes, 58
skin diseases and Kushtaroga,
31–32
therapeutic uses of
turmeric, 28
Tussnil syrup, 117
tyrosine hydroxylase, 95
UA. See ursolic acid (UA)
UAE. See ultrasound assisted ex-
traction (UAE)
UFLC/MS. See ultra-fast liquid chro-
matography/mass spectrometric
(UFLC/MS)
ultra-fast liquid chromatography/
mass spe ctrometric (UFLC/
MS), 180
ultra-high-performance liquid
chromatography (UPLC), 264
ultrasound assisted extraction
(UAE), 118–121, 124, 165–166
ultraviolet-B (UVB), 237
Universal Natural Products Database
(UNPD), 203
UNPD. See Universal Natural
Products Database (UNPD)
UPLC. See ultra-high-performance
liquid chromatography (UPLC)
12-ursene-2-diketone, 76
ursolic acid (UA), 130–131, 135
UVB. See ultraviolet-B (UVB)
Vacha (Acorus calamus
), 180
Vaman, 329
Vamshalochana (Bambusa
arundinacea), 154
Vangasen Samhita (VS), 26
440 Subject Index
https://t.me/med1917
VAS. See visual analogue scale
(VAS)
Vasaka (Adhatoda vasica ), 150, 152
vascular endothelial growth factor
(VEGF), 207
Vata, 328
vata-kshaya, 78
vatarakta, 26–27, 31
Vati, 9–10
Vayasthapananam shrestham, 222
VEGF. See vascular endothelial
growth factor (VEGF)
VEGF receptor-2 (VEGFR-2), 207
VEGFR-2. See VEGF receptor-2
(VEGFR-2)
Veldt Grape, 289
Vibhitaki (Terminalia bellirica),
228
vicenin, 112
vicenin-2 (VCN-2), 130
Vidanga (Embelia ribes), 180
vincristine, 392
viper (Daboia russelii), 99
visual analogue scale (VAS), 79
vitamins A and C, 112
Vitis vinifera. See Draksha
(Vitis vinifera)
Vivaldi gulika, 114
vomiting, management of, 63
VS. See Vangasen Samhita (VS)
WA. See withaferin-A (WA)
water-based formats, 27
water-soluble hydrotrope
molecules, 164
weight loss and obesity
CQ clinical studies for, 307–309
WHO.SeeWorld Health Organization
(WHO)
withaferin, 97
withaferin-A (WA), 96
Withania somnifera, 93, 305, 310,
377, 380, 382
withanolides, 92, 100
World Health Organization (WHO),
45, 110, 194
wound healing activity, CQ, 309
X-ray diffr action (XRD), 15, 92
XRD. See X-ray diffraction (XRD)
Yajur Veda, 176
Yinyang, 405
Yogaratnakar (YR), 26
YR. See Yogaratnakar (YR)
zinc-based formulas, 12
Zingiber officinale. See ginger (Zingiber
officinale)
Zingiber officinalis (ZO), 305
ZO. See Zingiber officinalis (ZO)
Subject Index 441
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана